Herbert Wentzien, OD
Optometrist · Anchorage, AKNPI 1316431257
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,083 of the $5,245 with a category attached, or 77.9%. 15 manufacturers reported payments, led by Biotissue Holdings Inc. at 41.0% of the total. 2025 is the largest year on record at $2,621, 7.7 times the $342 reported in 2019. Among optometrist clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $76.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$2K
- Alcon$1K
- Dompe US, Inc.$321
- Bausch & Lomb Americas Inc.$289
- Glaukos Corporation$208
- Tarsus Pharmaceuticals, Inc.$140
- plus $787 from 9 others
What the payments were for
- Travel & lodging$1,16222%
- Food & beverage$4,08378%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 9 | $2,153 |
| Alcon | 23 | $1,347 |
| Dompe US, Inc. | 7 | $321 |
| Bausch & Lomb Americas Inc. | 7 | $289 |
| Glaukos Corporation | 2 | $208 |
| Tarsus Pharmaceuticals, Inc. | 4 | $140 |
| Sun Pharmaceutical Industries Inc. | 3 | $128 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $125 |
| Oyster Point Pharma, Inc. | 5 | $124 |
| Shire North American Group Inc | 1 | $122 |
| Kedrion Biopharma, Inc. | 1 | $102 |
| Sight Sciences, Inc. | 2 | $88 |
| Coopervision Inc. | 2 | $53 |
| AbbVie | 1 | $23 |
| Thea Pharma Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$703
- DAILIES TOTAL1$238
- DAILIES$228
- Clareon$146
- Hydrus Microstent$142
- BIOTRUE$125
- ULTRA$125
- BIOTRUE ONE DAY$125
- Oxervate$125
- Precision 1$122
- TOTAL30$122
- XIIDRA$122
- AmnioGraft$122
- MIEBO$114
- KXL1B-CE-marked KXLsystem$104
- KXL System$104
- RYPLAZIM$102
How this compares
$5,245 in reported general payments places this provider in the 95th percentile of 163 optometrist providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 24 | $13,969 |
| Prednisolone Acetate | 13 | $510 |
| Latanoprost | 26 | $300 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Anchorage
- Andrea EberleAnchorage$10K
- Steven DobsonAnchorage$6K
- Nhan TranAnchorage$5K
- Bethany BeckerAnchorage$5K
- Elizabeth BowAnchorage$4K
- Anthony MakarAnchorage$4K
- Gary KjomeAnchorage$4K
- Christie StemmleAnchorage$4K
- Nathan FrankAnchorage$4K
- Rebecca MakarAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.